Levi R - Search Results

1

Hypoxic coronary vasodilatation and cGMP overproduction are blocked by a nitric oxide synthase inhibitor, but not by a guanylyl cyclase ANF receptor antagonist.

Park KH, Levi R. Park KH, et al. Among authors: levi r. Eur J Pharmacol. 1994 Apr 11;256(1):99-102. doi: 10.1016/0014-2999(94)90622-x. Eur J Pharmacol. 1994. PMID: 7517893

2

Nitric oxide and peripheral adrenergic neuromodulation.

Levi R, Park KH, Imamura M, Seyedi N, Lander HM. Levi R, et al. Adv Pharmacol. 1995;34:399-413. doi: 10.1016/s1054-3589(08)61100-x. Adv Pharmacol. 1995. PMID: 8562448 No abstract available.

3

Nitric oxide is a mediator of hypoxic coronary vasodilatation. Relation to adenosine and cyclooxygenase-derived metabolites.

Park KH, Rubin LE, Gross SS, Levi R. Park KH, et al. Among authors: levi r. Circ Res. 1992 Oct;71(4):992-1001. doi: 10.1161/01.res.71.4.992. Circ Res. 1992. PMID: 1325300

4

Tetrahydrobiopterin synthesis is induced by LPS in vascular smooth muscle and is rate-limiting for nitric oxide production.

Gross SS, Levi R, Madera A, Park KH, Vane J, Hattori Y. Gross SS, et al. Among authors: levi r. Adv Exp Med Biol. 1993;338:295-300. doi: 10.1007/978-1-4615-2960-6_61. Adv Exp Med Biol. 1993. PMID: 7508166 Review.

5

Novel selective hypotensive vasopressin peptides: cardiovascular and structure-activity-relationship studies.

Chan WY, Levi R, Wo NC, Koyama M, Stoev S, Cheng LL, Manning M. Chan WY, et al. Among authors: levi r. Eur J Pharmacol. 2001 May 4;419(1):65-72. doi: 10.1016/s0014-2999(01)00959-1. Eur J Pharmacol. 2001. PMID: 11348632

6

L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.

Fasehun OA, Gross SS, Rubin LE, Jaffe EA, Griffith OW, Levi R. Fasehun OA, et al. Among authors: levi r. J Pharmacol Exp Ther. 1990 Dec;255(3):1348-53. J Pharmacol Exp Ther. 1990. PMID: 2175803

7

Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion: role of adenosine A1/A3 and bradykinin B2 receptor activation.

Giannella E, Mochmann HC, Levi R. Giannella E, et al. Among authors: levi r. Circ Res. 1997 Sep;81(3):415-22. doi: 10.1161/01.res.81.3.415. Circ Res. 1997. PMID: 9285644

8

A central nervous system action of nitric oxide in blood pressure regulation.

Togashi H, Sakuma I, Yoshioka M, Kobayashi T, Yasuda H, Kitabatake A, Saito H, Gross SS, Levi R. Togashi H, et al. Among authors: levi r. J Pharmacol Exp Ther. 1992 Jul;262(1):343-7. J Pharmacol Exp Ther. 1992. PMID: 1378094

9

NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo?

Aisaka K, Gross SS, Griffith OW, Levi R. Aisaka K, et al. Among authors: levi r. Biochem Biophys Res Commun. 1989 Apr 28;160(2):881-6. doi: 10.1016/0006-291x(89)92517-5. Biochem Biophys Res Commun. 1989. PMID: 2719705 Free article.

10

Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels.

Endou M, Poli E, Levi R. Endou M, et al. Among authors: levi r. J Pharmacol Exp Ther. 1994 Apr;269(1):221-9. J Pharmacol Exp Ther. 1994. PMID: 8169830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

545 results

Search Page

Filters